Clinical significance of conduction disturbances after aortic valve intervention: current evidence

Clinical Research in Cardiology

Volumn 104, Issue 1, 2015, Pages

  Martinez Selles, Manuel ^a   Bramlage, Peter ^b   Thoenes, Martin ^c   Schymik, Gerhard ^d  

^a HOSPITAL GENERAL UNIVERSITARIO GREGORIO MARAÑÓN   (Spain)

^b Institute für Pharmakologie und Präventive Medizin   (Germany)

^c Léman Research Institute   (Switzerland)

^d STÄDTISCHES KLINIKUM KARLSRUHE   (Germany)

Author keywords

Conduction disturbance; Left bundle branch block; Pacemaker; Surgical aortic valve replacement; Transcatheter aortic valve Implantation

Indexed keywords

ADVERSE EFFECTS; AORTA VALVE; AORTIC VALVE STENOSIS; ARRHYTHMIAS, CARDIAC; ARTIFICIAL HEART PACEMAKER; COST BENEFIT ANALYSIS; ECONOMICS; HEALTH CARE COST; HEART CATHETERIZATION; HEART MUSCLE CONDUCTION SYSTEM; HEART PACING; HEART VALVE REPLACEMENT; HUMAN; PATHOPHYSIOLOGY; PROCEDURES; RISK ASSESSMENT; RISK FACTOR; TREATMENT OUTCOME;

AORTIC VALVE; AORTIC VALVE STENOSIS; ARRHYTHMIAS, CARDIAC; CARDIAC CATHETERIZATION; CARDIAC PACING, ARTIFICIAL; COST-BENEFIT ANALYSIS; HEALTH CARE COSTS; HEART CONDUCTION SYSTEM; HEART VALVE PROSTHESIS IMPLANTATION; HUMANS; PACEMAKER, ARTIFICIAL; RISK ASSESSMENT; RISK FACTORS; TREATMENT OUTCOME;

EID: 84939880049     PISSN: 18610684     EISSN: 18610692     Source Type: Journal    
DOI: 10.1007/s00392-014-0739-6     Document Type: Review

References (84)

1. Nkomo VT, Gardin JM, Skelton TN, Gottdiener JS, Scott CG, Enriquez-Sarano M (2006) Burden of valvular heart diseases: a population-based study. Lancet 368:1005–1011
2. Osnabrugge RL, Mylotte D, Head SJ, Van Mieghem NM, Nkomo VT, LeReun CM, Bogers AJ, Piazza N et al (2013) Aortic stenosis in the elderly: disease prevalence and number of candidates for transcatheter aortic valve replacement: a meta-analysis and modeling study. J Am Coll Cardiol 62:1002–1012
3. Cribier A (2012) Development of transcatheter aortic valve implantation (TAVI): a 20-year odyssey. Arch Cardiovasc Dis 105:146–152
4. McMurray JJ, Adamopoulos S, Anker SD, Auricchio A, Bohm M, Dickstein K, Falk V, Filippatos G et al (2012) ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2012: The Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association (HFA) of the ESC. Eur Heart J 33:1787–1847
5. Tang GH, Lansman SL, Cohen M, Spielvogel D, Cuomo L, Ahmad H, Dutta T (2013) Transcatheter aortic valve replacement: current developments, ongoing issues, future outlook. Cardiol Rev 21:55–76
6. Neragi-Miandoab S, Michler RE (2013) A review of most relevant complications of transcatheter aortic valve implantation. ISRN Cardiol 2013:956252
7. Kappetein AP, Head SJ, Genereux P, Piazza N, van Mieghem NM, Blackstone EH, Brott TG, Cohen DJ et al (2013) Updated standardized endpoint definitions for transcatheter aortic valve implantation: the Valve Academic Research Consortium-2 consensus document. J Thorac Cardiovasc Surg 145:6–23
8. Roten L, Meier B (2014) Left bundle branch block after transcatheter aortic valve implantation: still a matter of concern? JACC Cardiovasc Interv 7:137–139
9. Colombo A, Latib A (2012) Left bundle branch block after transcatheter aortic valve implantation: inconsequential or a clinically important endpoint? J Am Coll Cardiol 60:1753–1755
10. Fraccaro C, Napodano M, Tarantini G (2013) Conduction disorders in the setting of transcatheter aortic valve implantation: a clinical perspective. Catheter Cardiovasc Interv 81:1217–1223
11. Khatri PJ, Webb JG, Rodes-Cabau J, Fremes SE, Ruel M, Lau K, Guo H, Wijeysundera HC et al (2013) Adverse effects associated with transcatheter aortic valve implantation: a meta-analysis of contemporary studies. Ann Intern Med 158:35–46
12. Van Mieghem NM, Head SJ, de Jong W, van Domburg RT, Serruys PW, de Jaegere PP, Jordaens L, Takkenberg JJ et al (2012) Persistent annual permanent pacemaker implantation rate after surgical aortic valve replacement in patients with severe aortic stenosis. Ann Thorac Surg 94:1143–1149
13. Roten L, Stortecky S, Scarcia F, Kadner A, Tanner H, Delacretaz E, Meier B, Windecker S et al (2012) Atrioventricular conduction after transcatheter aortic valve implantation and surgical aortic valve replacement. J Cardiovasc Electrophysiol 23:1115–1122
14. Bagur R, Rodes-Cabau J, Gurvitch R, Dumont E, Velianou JL, Manazzoni J, Toggweiler S, Cheung A et al (2012) Need for permanent pacemaker as a complication of transcatheter aortic valve implantation and surgical aortic valve replacement in elderly patients with severe aortic stenosis and similar baseline electrocardiographic findings. JACC Cardiovasc Interv 5:540–551
15. Simms AD, Hogarth AJ, Hudson EA, Worsnop VL, Blackman DJ, O’Regan DJ, Tayebjee MH (2013) Ongoing requirement for pacing post-transcatheter aortic valve implantation and surgical aortic valve replacement. Interact Cardiovasc Thorac Surg 17:328–333
16. El-Khally Z, Thibault B, Staniloae C, Theroux P, Dubuc M, Roy D, Guerra P, Macle L et al (2004) Prognostic significance of newly acquired bundle branch block after aortic valve replacement. Am J Cardiol 94:1008–1011
17. Kalavrouziotis D, Li D, Buth KJ, Legare JF (2009) The European System for Cardiac Operative Risk Evaluation (EuroSCORE) is not appropriate for withholding surgery in high-risk patients with aortic stenosis: a retrospective cohort study. J Cardiothorac Surg 4:32
18. Akin I, Kische S, Paranskaya L, Schneider H, Rehders TC, Trautwein U, Turan G, Bansch D et al (2012) Predictive factors for pacemaker requirement after transcatheter aortic valve implantation. BMC Cardiovasc Disord 12:87
19. Baan J Jr, Yong ZY, Koch KT, Henriques JP, Bouma BJ, Vis MM, Cocchieri R, Piek JJ et al (2010) Factors associated with cardiac conduction disorders and permanent pacemaker implantation after percutaneous aortic valve implantation with the CoreValve prosthesis. Am Heart J 159:497–503
20. Bleiziffer S, Ruge H, Horer J, Hutter A, Geisbusch S, Brockmann G, Mazzitelli D, Bauernschmitt R et al (2010) Predictors for new-onset complete heart block after transcatheter aortic valve implantation. JACC Cardiovasc Interv 3:524–530
21. Buellesfeld L, Stortecky S, Heg D, Hausen S, Mueller R, Wenaweser P, Pilgrim T, Gloekler S et al (2012) Impact of permanent pacemaker implantation on clinical outcome among patients undergoing transcatheter aortic valve implantation. J Am Coll Cardiol 60:493–501
22. Franzoni I, Latib A, Maisano F, Costopoulos C, Testa L, Figini F, Giannini F, Basavarajaiah S et al (2013) Comparison of incidence and predictors of left bundle branch block after transcatheter aortic valve implantation using the CoreValve versus the Edwards valve. Am J Cardiol 112:554–559
23. Goldenberg G, Kusniec J, Kadmon E, Golovchiner G, Zabarsky R, Nevzorov R, Vaknin H, Assali A et al (2013) Pacemaker implantation after transcatheter aortic valve implantation. Am J Cardiol 112:1632–1634
24. Grube E, Naber C, Abizaid A, Sousa E, Mendiz O, Lemos P, Kalil Filho R, Mangione J et al (2011) Feasibility of transcatheter aortic valve implantation without balloon pre-dilation: a pilot study. JACC Cardiovasc Interv 4:751–757
25. Koos R, Mahnken AH, Aktug O, Dohmen G, Autschbach R, Marx N, Hoffmann R (2011) Electrocardiographic and imaging predictors for permanent pacemaker requirement after transcatheter aortic valve implantation. J Heart Valve Dis 20:83–90
26. Liang M, Devlin G, Pasupati S (2012) The incidence of transcatheter aortic valve implantation-related heart block in self-expandable Medtronic CoreValve and balloon-expandable Edwards valves. J Invasive Cardiol 24:173–176
27. Mouillet G, Lellouche N, Lim P, Meguro K, Yamamoto M, Deux JF, Monin JL, Bergoend E et al (2013) Patients without prolonged QRS after TAVI with CoreValve device do not experience high-degree atrio-ventricular block. Catheter Cardiovasc Interv 81:882–887
28. Pereira E, Ferreira N, Caeiro D, Primo J, Adao L, Oliveira M, Goncalves H, Ribeiro J et al (2013) Transcatheter aortic valve implantation and requirements of pacing over time. Pacing Clin Electrophysiol 36:559–569
29. Piazza N, Onuma Y, Jesserun E, Kint PP, Maugenest AM, Anderson RH, de Jaegere PP, Serruys PW (2008) Early and persistent intraventricular conduction abnormalities and requirements for pacemaking after percutaneous replacement of the aortic valve. JACC Cardiovasc Interv 1:310–316
30. Piazza N, Nuis RJ, Tzikas A, Otten A, Onuma Y, Garcia-Garcia H, Schultz C, van Domburg R et al (2010) Persistent conduction abnormalities and requirements for pacemaking 6 months after transcatheter aortic valve implantation. Eurointervention 6:475–484
31. Roten L, Wenaweser P, Delacretaz E, Hellige G, Stortecky S, Tanner H, Pilgrim T, Kadner A et al (2010) Incidence and predictors of atrioventricular conduction impairment after transcatheter aortic valve implantation. Am J Cardiol 106:1473–1480
32. Saia F, Lemos PA, Bordoni B, Cervi E, Boriani G, Ciuca C, Taglieri N, Mariani J Jr et al (2012) Transcatheter aortic valve implantation with a self-expanding nitinol bioprosthesis: prediction of the need for permanent pacemaker using simple baseline and procedural characteristics. Catheter Cardiovasc Interv 79:712–719
33. Schroeter T, Linke A, Haensig M, Merk DR, Borger MA, Mohr FW, Schuler G (2012) Predictors of permanent pacemaker implantation after Medtronic CoreValve bioprosthesis implantation. Europace 14:1759–1763
34. Houthuizen P, Van Garsse LA, Poels TT, de Jaegere P, van der Boon RM, Swinkels BM, Ten Berg JM, van der Kley F et al (2012) Left bundle-branch block induced by transcatheter aortic valve implantation increases risk of death. Circulation 126:720–728
35. van der Boon RM, Van Mieghem NM, Theuns DA, Nuis RJ, Nauta ST, Serruys PW, Jordaens L, van Domburg RT et al (2013) Pacemaker dependency after transcatheter aortic valve implantation with the self-expanding Medtronic CoreValve System. Int J Cardiol 168:1269–1273
36. Ferreira ND, Caeiro D, Adao L, Oliveira M, Goncalves H, Ribeiro J, Teixeira M, Albuquerque A et al (2010) Incidence and predictors of permanent pacemaker requirement after transcatheter aortic valve implantation with a self-expanding bioprosthesis. Pacing Clin Electrophysiol 33:1364–1372
37. Erkapic D, Kim WK, Weber M, Mollmann H, Berkowitsch A, Zaltsberg S, Pajitnev DJ, Rixe J et al (2010) Electrocardiographic and further predictors for permanent pacemaker requirement after transcatheter aortic valve implantation. Europace 12:1188–1190
38. Nijhoff F, Agostoni P, Amrane H, Latib A, Testa L, Oreglia JA, De Marco F, Samim M et al (2013) Transcatheter aortic valve implantation in patients with severe aortic valve stenosis and large aortic annulus, using the self-expanding 31-mm Medtronic CoreValve prosthesis: first clinical experience. J Thorac Cardiovasc Surg. doi:10.1016/j.jtcvs.2013.09.059
39. Blackman DJ, Baxter PD, Gale CP, Moat NE, Maccarthy PA, Hildick-Smith D, Trivedi U, Cunningham D et al (2014) Do outcomes from transcatheter aortic valve implantation vary according to access route and valve type? The UK TAVI Registry. J Interv Cardiol 27:86–95
40. Kraus JDF, Hammerer M, Schneider J, Hoppe U, Strohmer B (2013) Pacemaker dependency after transaortic valve implantation. Osterreichische Kardiologische Gesellschaft Jahrestagung Wiener Med Wochenschr 125:s43–s43
41. Bjerre Thygesen J, Loh PH, Cholteesupachai J, Franzen O, Sondergaard L (2014) Reevaluation of the indications for permanent pacemaker implantation after transcatheter aortic valve implantation. J Invasive Cardiol 26:94–99
42. Gutierrez M, Rodes-Cabau J, Bagur R, Doyle D, DeLarochelliere R, Bergeron S, Lemieux J, Villeneuve J et al (2009) Electrocardiographic changes and clinical outcomes after transapical aortic valve implantation. Am Heart J 158:302–308
43. Laynez A, Ben-Dor I, Barbash IM, Hauville C, Sardi G, Maluenda G, Xue Z, Satler LF et al (2012) Frequency of conduction disturbances after Edwards SAPIEN percutaneous valve implantation. Am J Cardiol 110:1164–1168
44. Binder RK, Webb JG, Toggweiler S, Freeman M, Barbanti M, Willson AB, Alhassan D, Hague CJ et al (2013) Impact of post-implant SAPIEN XT geometry and position on conduction disturbances, hemodynamic performance, and paravalvular regurgitation. JACC Cardiovasc Interv 6:462–468
45. Urena M, Webb JG, Tamburino C, Munoz-Garcia AJ, Cheema A, Dager AE, Serra V, Amat-Santos IJ et al (2014) Permanent pacemaker implantation after transcatheter aortic valve implantation: impact on late clinical outcomes and left ventricular function. Circulation 129:1233–1243
46. Martinez-Selles M, Gomez Doblas JJ, Carro Hevia A, Garcia de la Villa B, Ferreira-Gonzalez I, Alonso Tello A, Andion Ogando R, Ripoll Vera T et al (2014) Prospective registry of symptomatic severe aortic stenosis in octogenarians: a need for intervention. J Intern Med 275:608–620
47. Jilaihawi H, Chakravarty T, Weiss RE, Fontana GP, Forrester J, Makkar RR (2012) Meta-analysis of complications in aortic valve replacement: comparison of Medtronic-Corevalve, Edwards-Sapien and surgical aortic valve replacement in 8,536 patients. Catheter Cardiovasc Interv 80:128–138
48. Fournial JF, Brodaty D, Chomette G, Tereau Y, Cabrol C, Acar J (1979) Conduction disorders after aortic valve replacement. Apropos of 200 cases. Arch Mal Coeur Vaiss 72:4–11
49. Thomas JL, Dickstein RA, Parker FB Jr, Potts JL, Poirier RA, Fruehan CT, Eich RH (1982) Prognostic significance of the development of left bundle conduction defects following aortic valve replacement. J Thorac Cardiovasc Surg 84:382–386
50. Kolh P, Kerzmann A, Honore C, Comte L, Limet R (2007) Aortic valve surgery in octogenarians: predictive factors for operative and long-term results. Eur J Cardiothorac Surg 31:600–606
51. Aktug O, Dohmen G, Brehmer K, Koos R, Altiok E, Deserno V, Herpertz R, Autschbach R et al (2012) Incidence and predictors of left bundle branch block after transcatheter aortic valve implantation. Int J Cardiol 160:26–30
52. Nuis RJ, Van Mieghem NM, Schultz CJ, Tzikas A, Van der Boon RM, Maugenest AM, Cheng J, Piazza N et al (2011) Timing and potential mechanisms of new conduction abnormalities during the implantation of the Medtronic CoreValve System in patients with aortic stenosis. Eur Heart J 32:2067–2074
53. Tzikas A, van Dalen BM, Van Mieghem NM, Gutierrez-Chico JL, Nuis RJ, Kauer F, Schultz C, Serruys PW et al (2011) Frequency of conduction abnormalities after transcatheter aortic valve implantation with the Medtronic-CoreValve and the effect on left ventricular ejection fraction. Am J Cardiol 107:285–289
54. Urena M, Mok M, Serra V, Dumont E, Nombela-Franco L, DeLarochelliere R, Doyle D, Igual A et al (2012) Predictive factors and long-term clinical consequences of persistent left bundle branch block following transcatheter aortic valve implantation with a balloon-expandable valve. J Am Coll Cardiol 60:1743–1752
55. Nazif TM, Williams MR, Hahn RT, Kapadia S, Babaliaros V, Rodes-Cabau J, Szeto WY, Jilaihawi H et al (2014) Clinical implications of new-onset left bundle branch block after transcatheter aortic valve replacement: analysis of the PARTNER experience. Eur Heart J 32:1599–1607
56. Mukherjee C, Busse H, Mende M, Banusch J, Feussner M, Ender J (2013) Incidence and outcome of artioventricular block after transcatheter aortic valve implantation (TAVI): analysis in 994 patients. In: EACTA, pp 139–140
57. Schwerg M, Baldenhofer G, Dreger H, Bondke H, Stangl K, Laule M, Melzer C (2013) Complete atrioventricular block after TAVI: when is pacemaker implantation safe? Pacing Clin Electrophysiol 36:898–903
58. Bagur R, Manazzoni JM, Dumont E, Doyle D, Perron J, Dagenais F, Mathieu P, Baillot R et al (2011) Permanent pacemaker implantation following isolated aortic valve replacement in a large cohort of elderly patients with severe aortic stenosis. Heart 97:1687–1694
59. Onorati F, D’Errigo P, Barbanti M, Rosato S, Covello DR, Maraschini A, Ranucci M, Grossi C et al (2013) Results differ between transaortic and open surgical aortic valve replacement in women. Ann Thorac Surg 96:1336–1342
60. Brignole M, Auricchio A, Baron-Esquivias G, Bordachar P, Boriani G, Breithardt OA, Cleland J, Deharo JC et al (2013) 2013 ESC guidelines on cardiac pacing and cardiac resynchronization therapy: the task force on cardiac pacing and resynchronization therapy of the European Society of Cardiology (ESC). Developed in collaboration with the European Heart Rhythm Association (EHRA). Europace 15:1070–1118
61. Ghadimi K, Patel PA, Gutsche JT, Sophocles A, Anwaruddin S, Szeto WY, Augoustides JG (2013) Perioperative conduction disturbances after transcatheter aortic valve replacement. J Cardiothorac Vasc Anesth 27:1414–1420
62. Anderson RH, Boyett MR, Dobrzynski H, Moorman AF (2013) The anatomy of the conduction system: implications for the clinical cardiologist. J Cardiovasc Transl Res 6:187–196
63. Moreno R, Dobarro D, Lopez de Sa E, Prieto M, Morales C, Calvo Orbe L, Moreno-Gomez I, Filgueiras D et al (2009) Cause of complete atrioventricular block after percutaneous aortic valve implantation: insights from a necropsy study. Circulation 120:e29–e30
64. Toutouzas K, Synetos A, Tousoulis D, Latsios G, Brili S, Mastrokostopoulos A, Karanasos A, Sideris S et al (2014) Predictors for permanent pacemaker implantation after core valve implantation in patients without preexisting ECG conduction disturbances: the role of a new echocardiographic index. Int J Cardiol 172:601–603
65. Tzamtzis S, Viquerat J, Yap J, Mullen MJ, Burriesci G (2013) Numerical analysis of the radial force produced by the Medtronic-CoreValve and Edwards-SAPIEN after transcatheter aortic valve implantation (TAVI). Med Eng Phys 35:125–130
66. Buellesfeld L, Stortecky S, Kalesan B, Gloekler S, Khattab AA, Nietlispach F, Delfine V, Huber C et al (2013) Aortic root dimensions among patients with severe aortic stenosis undergoing transcatheter aortic valve replacement. JACC Cardiovasc Interv 6:72–83
67. Breithardt G, Breithardt OA (2012) Left bundle branch block, an old-new entity. J Cardiovasc Transl Res 5:107–116
68. Erkapic D, De Rosa S, Kelava A, Lehmann R, Fichtlscherer S, Hohnloser SH (2012) Risk for permanent pacemaker after transcatheter aortic valve implantation: a comprehensive analysis of the literature. J Cardiovasc Electrophysiol 23:391–397
69. Moat NE, Ludman P, de Belder MA, Bridgewater B, Cunningham AD, Young CP, Thomas M, Kovac J et al (2011) Long-term outcomes after transcatheter aortic valve implantation in high-risk patients with severe aortic stenosis: the U.K. TAVI (United Kingdom Transcatheter Aortic Valve Implantation) Registry. J Am Coll Cardiol 58:2130–2138
70. Elmariah S, Palacios IF, McAndrew T, Hueter I, Inglessis I, Baker JN, Kodali S, Leon MB et al (2013) Outcomes of transcatheter and surgical aortic valve replacement in high-risk patients with aortic stenosis and left ventricular dysfunction: results from the Placement of Aortic Transcatheter Valves (PARTNER) trial (cohort A). Circ Cardiovasc Interv 6:604–614
71. Hoffmann R, Herpertz R, Lotfipour S, Aktug O, Brehmer K, Lehmacher W, Autschbach R, Marx N et al (2012) Impact of a new conduction defect after transcatheter aortic valve implantation on left ventricular function. JACC Cardiovasc Interv 5:1257–1263
72. Khawaja MZ, Rajani R, Cook A, Khavandi A, Moynagh A, Chowdhary S, Spence MS, Brown S et al (2011) Permanent pacemaker insertion after CoreValve transcatheter aortic valve implantation: incidence and contributing factors (the UK CoreValve Collaborative). Circulation 123:951–960
73. Sinning JM, Werner N, Nickenig G, Grube E (2012) Next-generation transcatheter heart valves: current trials in Europe and the USA. Methodist Debakey Cardiovasc J 8:9–12
74. Binder RK, Rodes-Cabau J, Wood DA, Mok M, Leipsic J, De Larochelliere R, Toggweiler S, Dumont E et al (2013) Transcatheter aortic valve replacement with the SAPIEN 3: a new balloon-expandable transcatheter heart valve. JACC Cardiovasc Interv 6:293–300
75. Falk V, Walther T, Schwammenthal E, Strauch J, Aicher D, Wahlers T, Schafers J, Linke A et al (2011) Transapical aortic valve implantation with a self-expanding anatomically oriented valve. Eur Heart J 32:878–887
76. Willson AB, Rodes-Cabau J, Wood DA, Leipsic J, Cheung A, Toggweiler S, Binder RK, Freeman M et al (2012) Transcatheter aortic valve replacement with the St. Jude Medical Portico valve: first-in-human experience. J Am Coll Cardiol 60:581–586
77. Treede H, Mohr FW, Baldus S, Rastan A, Ensminger S, Arnold M, Kempfert J, Figulla HR (2012) Transapical transcatheter aortic valve implantation using the JenaValve system: acute and 30-day results of the multicentre CE-mark study. Eur J Cardiothorac Surg 41:e131–e138
78. Schofer J, Schluter M, Treede H, Franzen OW, Tubler T, Pascotto A, Low RI, Bolling SF et al (2008) Retrograde transarterial implantation of a nonmetallic aortic valve prosthesis in high-surgical-risk patients with severe aortic stenosis: a first-in-man feasibility and safety study. Circ Cardiovasc Interv 1:126–133
79. Zembala MO, Piegza J, Waclawski J, Hawranek M, Hilker M, Niklewski T, Glowacki J, Parys M et al (2014) Symetis Acurate Transapical Aortic Valve: the initial experience with a second generation of transcatheter aortic valve replacement device. Kardiol Pol 72:187–193
80. Seiffert M, Conradi L, Kloth B, Koschyk D, Schirmer J, Schnabel RB, Blankenberg S, Reichenspurner H et al (2014) Single-centre experience with next-generation devices for transapical aortic valve implantation. Eur J Cardiothorac Surg [Epub ahead of print]
81. Orlando R, Pennant M, Rooney S, Khogali S, Bayliss S, Hassan A, Moore D, Barton P (2013) Cost-effectiveness of transcatheter aortic valve implantation (TAVI) for aortic stenosis in patients who are high risk or contraindicated for surgery: a model-based economic evaluation. Health Technol Assess 17:1–86
82. Osman F, Krishnamoorthy S, Nadir A, Mullin P, Morley-Davies A, Creamer J (2010) Safety and cost-effectiveness of same day permanent pacemaker implantation. Am J Cardiol 106:383–385
83. Greenspon AJ, Patel JD, Lau E, Ochoa JA, Frisch DR, Ho RT, Pavri BB, Kurtz SM (2012) Trends in permanent pacemaker implantation in the United States from 1993 to 2009: increasing complexity of patients and procedures. J Am Coll Cardiol 60:1540–1545
84. Naber CTM, Bramlage P, Wasem J (2014) The impact of TAVI related permanent pacemaker implantation on the German healthcare system. Eurointervention 14A-OP319